Nuzenio

S Repatha

S Repatha entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 2 latest news signals 2 publisher sources 100/100 entity strength

Latest news

Amgen remains bullish on Repatha, axes obesity asset in 2Q report - FirstWord PHARMAFirstWord PHARMA · Wed, 05 Aug 2026 01:51:57 GMT EQS-News: POSITIVE CHMP OPINION SUPPORTS BROADER USE OF AMGEN'S REPATHA® BEFORE A FIRST HEART ATTACK OR STROKE - boerse.de - boerse.deboerse.de · Wed, 29 Jul 2026 13:05:00 GMT

Timeline

Wed, 05 Aug 2026 01:51:57 GMTAmgen remains bullish on Repatha, axes obesity asset in 2Q report - FirstWord PHARMA

Wed, 29 Jul 2026 13:05:00 GMTEQS-News: POSITIVE CHMP OPINION SUPPORTS BROADER USE OF AMGEN'S REPATHA® BEFORE A FIRST HEART ATTACK OR STROKE - boerse.de - boerse.de

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.

Connected entities

Repatha2 live mentions EQS2 live mentions POSITIVE CHMP OPINION2 live mentions SUPPORTS BROADER USE2 live mentions OF AMGEN2 live mentions BEFORE A FIRST2 live mentions HEART ATTACK OR2 live mentions STROKE2 live mentions Amgen1 live mentions FirstWord PHARMA Amgen1 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for S Repatha.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.